Smet-Nocca, C.; Lippens, G.; Hilaire, G.; Gijsen H.; et al. Growing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L mice. PLoS One particular 2013, doi:10.1371/journal.pone.0084442. 158. Liu, F.; Shi, J.; Tanimukai, H.; Gu, J.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. Lowered O-GlcNAcylation hyperlinks reduced brain glucose metabolism and tau pathology in Alzheimer’s illness. Brain 2009, 132, 1820832. 159. Takahashi, M.; Tsujioka, Y.; Yamada, T.; Tsuboi, Y.; Okada, H.; Yamamoto, T.; Liposits, Z. Glycosylation of microtubule-associated protein tau in Alzheimer’s disease brain. Acta Neuropathol. 1999, 7, 63541. 160. Ledesma, M.D.; Medina, M.; Avila, J.; The in vitro formation of recombinant tau polymers: Impact of phosphorylation and glycation. Mol. Chem. Neuropathol. 1996, 27, 24958. 161. Su, B.; Wang, X.; Lee, H.G.; Tabaton, M.; Perry, G.; Smith, M.A.; Zhu, X. Chronic oxidative strain causes elevated tau phosphorylation in M17 neuroblastoma cells. Neurosci. Lett. 2010, 468, 26771. 162. Zhang, Y.J.; Xu, Y.F.; Liu, Y.H.; Yin, J.; Li, H.L.; Wang, Q.; Wang, J.Z. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB J. 2006, 20, 1431442. 163. Singer, S.M.; Zainelli, G.M.; Norlund, M.A.; Lee, J.M.; Muma, N.A. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer’s illness. Neurochem. Int. 2002, 40, 170. 164. Bancher, C.; Grundke-Iqbal, I.; Iqbal, K.; Fried, V.A.; Smith, H.T.; Wisniewski, H.M. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res. 1991, 539, 118. 165. Riederer, I.M.; Schiffrin, M.; Kovari, E.; Bouras, C.; Riederer, B.M. Ubiquitination and cysteine nitrosylation in the course of aging and Alzheimer’s disease. Brain Res. Bull. 2009, 80, 23341. 166. Takahashi, K.; Ishida, M.; Komano, H.; Takahashi, H. SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice. Neurosci. Lett. 2008, 441, 903. 167. Newman, M.; Musgrave, I.F.; Lardelli, M. Alzheimer illness: Amyloidogenesis, the presenilins and animal models. Biochim. Biophys. Acta 2007, 1772, 28597. 168. Amadoro, G.; Corsetti, V.; Ciotti, M.T.; Florenzano, F.; Capsoni, S.; Amato, G.; Calissano, P. Endogenous A causes cell death through early tau phosphorylation. Neurobiol. Aging 2011, 32, 96990. 169.Triclosan Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer’s disease: Progress and difficulties on the road to therapeutics.Vipivotide tetraxetan Science 2002, 297, 35356.PMID:24834360 170. Ittner, L.M.; G z, J. Amyloid- and tau–A toxic pas de deux in Alzheimer’s disease. Nat. Rev. Neurosci. 2011, 12, 672.Int. J. Mol. Sci. 2014,171. Vossel, K.A.; Zhang, K.; Brodbeck, J.; Daub, A.C.; Sharma, P.; Finkbeiner, S.; Cui, B.; Mucke, L. Tau reduction prevents A-induced defects in axonal transport. Science 2010, 330, 198. 172. Fein, J.A.; Sokolow, S.; Miller, C.A.; Vinters, H.V.; Yang, F.; Cole, G.M.; Gylys, K.H. Co-localization of amyloid beta and tau pathology in Alzheimer’s illness synaptosomes. Am. J. Pathol. 2008, 172, 1683692. 173. Takahashi, R.H.; Capetillo-Zarate, E.; Lin, M.T.; Milner, T.A.; Gouras, G.K. Co-occurrence of Alzheimer’s disease beta-amyloid and tau pathologies at synapses. Neurobiol. Aging 2010, 31, 1145152. 174. Du, H.; Guo, L.; Yan, S.; Sosunov, A.A.; McKhann, G.M.; Yan, S.S. Early deficits in synaptic mitochondria in an Alzheimer’s illness mouse model, Proc. Natl. A.